Old Web
English
Sign In
Acemap
>
authorDetail
>
Rudinei Diogo Marques Linck
Rudinei Diogo Marques Linck
Medicine
Renal cell carcinoma
Adverse effect
Sunitinib
Pathology
4
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias
2018
Endocrine-related Cancer
Paula Fontes Asprino
Rudinei Diogo Marques Linck
Jonatas Cesar
Florêncio Porto Freitas
Fernanda Christtanini Koyama
Rachel P. Riechelmann
Frederico Costa
Paulo M. Hoff
Pedro A. F. Galante
Diogo Meyer
Anamaria A. Camargo
Jorge Sabbaga
Show All
Source
Cite
Save
Citations (5)
Cancer immunology and melanoma immunotherapy
2017
Anais Brasileiros De Dermatologia
Rudinei Diogo Marques Linck
Rômulo Leopoldo de Paula Costa
Bernardo Garicochea
Show All
Source
Cite
Save
Citations (5)
Activity and safety of sunitinib in poor risk metastatic renal cell carcinoma patients
2014
International Braz J Urol
Romualdo Barroso-Sousa
Rodrigo Ramella Munhoz
Milena Perez Mak
Leonardo Gomes da Fonseca
A. B. Fede
Rudinei Diogo Marques Linck
Clovis Rego Coelho
Camila Motta Venchiarutti Moniz
Ciro Eduardo Souza
Carlos Dzik
Show All
Source
Cite
Save
Citations (2)
Outcomes of sunitinib therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) with poor risk features.
2013
Journal of Clinical Oncology
Romualdo Barroso-Sousa
Rodrigo Ramella Munhoz
Leonardo Gomes da Fonseca
Angelo Bezerra de Sousa Fede
Rudinei Diogo Marques Linck
Camila Motta Venchiarutti Moniz
Milena Perez Mak
Ciro Eduardo Souza
Paulo M. Hoff
Carlos Dzik
Show All
Source
Cite
Save
Citations (0)
1